Insider Trading activities at Immune Response Corp (IMNR)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Immune Response Corp (IMNR) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Immune Response Corp. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 817785.

Total stock buying since 2005: $98,880.
Total stock sales since 2005: $21,936,244.
Total stock option exercises since 2005: $0.

▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies


Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Immune Response Corp (IMNR).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2006 3,600,000 $79,400 11,250,000 $21,936,244 0 $0
2005 9,683,060 $19,480 0 $0 0 $0

Table 2. Monthly summary of insider trading at Immune Response Corp (IMNR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2006-11 0 $0 7,145,000 $13,729,794 0 $0
2006-10 0 $0 1,075,000 $2,146,450 0 $0
2006-09 0 $0 2,330,000 $4,660,000 0 $0
2006-08 500,000 $9,000 700,000 $1,400,000 0 $0
2006-07 2,900,000 $66,400 0 $0 0 $0
2006-06 200,000 $4,000 0 $0 0 $0
2005-09 9,683,060 $19,480 0 $0 0 $0

Table 3. Detailed insider trading at Immune Response Corp (IMNR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2006-11-09 Green Michael K (COO and CFO) Sale 2,474,900 1.92 4,751,808
2006-11-08 Green Michael K (COO and CFO) Sale 1,770,000 1.90 3,363,000
2006-11-07 Green Michael K (COO and CFO) Sale 325,600 1.91 621,896
2006-11-06 Green Michael K (COO and CFO) Sale 158,000 1.91 301,780
2006-11-03 Green Michael K (COO and CFO) Sale 1,042,500 1.92 2,001,600
2006-11-02 Green Michael K (COO and CFO) Sale 1,041,000 1.96 2,040,360
2006-11-01 Green Michael K (COO and CFO) Sale 333,000 1.95 649,350
2006-10-31 Green Michael K (COO and CFO) Sale 355,000 1.99 706,450
2006-10-19 Theofan Georgia (VP, Clinical Development) Sale 720,000 2.00 1,440,000
2006-09-15 Theofan Georgia (VP, Clinical Development) Sale 150,000 2.00 300,000
2006-09-08 Theofan Georgia (VP, Clinical Development) Sale 2,180,000 2.00 4,360,000
2006-08-31 Theofan Georgia (VP, Clinical Development) Sale 200,000 2.00 400,000
2006-08-29 Theofan Georgia (VP, Clinical Development) Sale 250,000 2.00 500,000
2006-08-25 Theofan Georgia (VP, Clinical Development) Sale 250,000 2.00 500,000
2006-08-21 Hochman David P (Director) Buy 500,000 .02 9,000
2006-07-28 Hochman David P (Director) Buy 2,600,000 .02 59,800
2006-07-27 Hochman David P (Director) Buy 300,000 .02 6,600
2006-06-19 Hochman David P (Director) Buy 200,000 .02 4,000
2005-09-22 Kimberlin Kevin (10% Owner) Buy 9,643,060 .00 0
2005-09-06 Green Michael K (VP, Finance and CFO) Buy 30,000 .50 14,880
2005-09-02 Bonfiglio John N (CEO) Buy 10,000 .46 4,600

Insider trading activities including stock purchases, stock sales, and option exercises of IMNR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Immune Response Corp (symbol IMNR, CIK number 817785) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.